2015. Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer. Journal of Analytical Oncology. 4, 1 (Jan. 2015),  44–51. DOI:https://doi.org/10.6000/1927-7229.2015.04.01.8.